It's a shame that there's no mention of the migraine related breakthroughs. Two new types of drugs that target CGRP (Calcitonin gene-related peptide) were approved and brought to market. One type is sold as injections and is used to prevent migraines, the other type is a tablet that's used to stop an acute migraine.

About a billion (!) people are affected by migraines, so any new treatment has the potential to be very beneficial.